Angiodynamics, Inc. (ANGO) Tops Q2 EPS by 1c; Guides Q3, Q4, FY12 EPS and Revs
Get Alerts ANGO Hot Sheet
Price: $6.17 -2.53%
Revenue Growth %: -18.2%
Financial Fact:
Interest income: 4K
Today's EPS Names:
ESCA, LICT, NKSH, More
Revenue Growth %: -18.2%
Financial Fact:
Interest income: 4K
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Angiodynamics, Inc. (NASDAQ: ANGO) reported Q2 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $53.4 million versus the consensus estimate of $56.26 million.
Angiodynamics, Inc. sees Q3 2012 EPS of $0.09-$0.11, versus the consensus of $0.11. Angiodynamics, Inc. sees Q3 2012 revenue of $52-$54 million, versus the consensus of $54.65 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.11-$0.13. Angiodynamics, Inc. sees Q4 2012 revenue of $53.5-$55.5 million.
Angiodynamics, Inc. sees FY2012 EPS of $0.41-$0.45, versus the consensus of $0.44. Angiodynamics, Inc. sees FY2012 revenue of $218-$222 million, versus the consensus of $219.9 million.
Angiodynamics, Inc. sees Q3 2012 EPS of $0.09-$0.11, versus the consensus of $0.11. Angiodynamics, Inc. sees Q3 2012 revenue of $52-$54 million, versus the consensus of $54.65 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.11-$0.13. Angiodynamics, Inc. sees Q4 2012 revenue of $53.5-$55.5 million.
Angiodynamics, Inc. sees FY2012 EPS of $0.41-$0.45, versus the consensus of $0.44. Angiodynamics, Inc. sees FY2012 revenue of $218-$222 million, versus the consensus of $219.9 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- KeyCorp (KEY) Misses Q1 EPS by 2c
- Alaska Air Group (ALK) Tops Q1 EPS by 11c, offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!